New Delhi, August 31, 2020: Highlights: Q1’fy 2020-21 (Consolidated) Performance at a Glance (Rs. in Crores) Particulars Q1’FY 2020-21 Q1’FY 2019-20…
New Delhi, April 30, 2020: Morepen Laboratories Ltd. has received the prestigious ISO-13485 certification from BSI (British Standards Institution, U.K.)…
Company gets license to manufacture Hydroxychloroquine (HCQ) New Delhi, April 20, 2020: Morepen Laboratories Ltd. is all set to be…
Highlights of Q3 FY 2019-20 (Consolidated): The Net Profit after Tax during the period stood at Rs. 10.81 crore, up…
New Delhi, November 28, 2019: Morepen Laboratories Ltd. has reported a Net sales Revenue (Standalone) of Rs. 383.30 crore in…
New Delhi, Delhi, India Highlights Q1 FY 2019-20 (Standalone): Net Sales Revenue recorded a pure organic growth of 25.4 per…
Company reports 93 percent rise in its consolidated net profit and 26 percent rise in its consolidated net sales revenue…
Baddi facility gets US FDA nod for bulk drug “Atorvastatin” and Masulkhana facility for “Montelukast” New Delhi, August 05, 2018:…